Preparation and characterization of paclitaxel microspheres in situ gel and its antitumor efficacy by local injection

  • Ying ZHAN ,
  • Yi-tian DU ,
  • Zhen-zhen YANG ,
  • Chun-li ZHANG ,
  • Xian-rong QI
Expand

Received date: 2019-03-22

  Online published: 2019-06-26

Supported by

Supported by the National Natural Science Foundation of China (81673365) and the Fundamental Research Funds for the Central Universities: Peking University Medicine Seed Fund for Interdisciplinary Research (BMU2018MX009)

Abstract

Objective: The current difficulties in the treatment of tumor include repeated administration and high recurrence rate after tumor resection. In order to reduce the number of doses, avoid side effects of chemotherapeutic drugs, suppress tumor growth and delay tumor recurrence after surgery, a temperature-sensitive in situ gel with paclitaxel microspheres (PTX/M gel) was prepared. PTX/M gel was administered by intratumoral injection once a month.Methods: First of all, paclitaxel microspheres (PTX/M) were prepared by emulsion solvent evaporation method. A laser particle size distribution analyzer was used to investigate the size, distribution, specific surface area of microspheres. Paclitaxel content was determined by high performance liquid chromatography (HPLC). Then encapsulation efficiency of paclita-xel was calculated and in vitro release characteristics were studied. Secondly, PTX/M gel was prepared by cold dissolution method. The phase transition temperature, elastic modulus, dissolution curve, correlation between dissolution and release were measured. Finally, U87 MG and 4T1 subcutaneous tumor mo-dels were established respectively to study the efficacy of PTX/M gel in suppressing tumor growth and delaying tumor recurrence after surgery.Results: The median diameter of the selected PTX/M was (32.24±1.09) μm, the specific surface area was (206.61±10.23) m 2/kg, the encapsulation efficiency was 85.29%±1.34%, and the cumulative release percentage of paclitaxel from PTX/M was 33.56%±3.33% in one month. Phase transition temperature of PTX/M gel was 33 ℃. The elastic modulus of PTX/M gel at 25 ℃ and 37 ℃ were 4.2×10 3 Pa and 18×10 3 Pa, respectively. The gel could stay in the body for up to 48 hours. It could be seen from the results of animal experiments that were compared with the saline group and the Taxol group, and the tumor-bearing mice of the PTX/M gel group had the slowest tumor growth (P<0.05). Similarly, in the tumor recurrence experiments, the mice of PTX/M gel group had the latest tumor recurrence after surgery. Conclusion: As a local sustained-release preparation, PTX/M gel can effectively suppress tumor growth and delay postoperative recurrence of tumors. It has potential advantages in tumor treatment.

Cite this article

Ying ZHAN , Yi-tian DU , Zhen-zhen YANG , Chun-li ZHANG , Xian-rong QI . Preparation and characterization of paclitaxel microspheres in situ gel and its antitumor efficacy by local injection[J]. Journal of Peking University(Health Sciences), 2019 , 51(3) : 477 -486 . DOI: 10.19723/j.issn.1671-167X.2019.03.015

References

[1] Gladson CL, Prayson RA, Liu WM . The pathobiology of glioma tumors[J]. Annu Rev Pathol, 2010,5(1):33-50.
[2] Fan L, Strasser-Weippl K, Li JJ , et al. Breast cancer in China[J]. Lancet Oncol, 2014,15(7):e279-e289.
[3] Marupudi N . Paclitaxel: a review of adverse toxicities and novel delivery strategies[J]. Expert Opin Drug Saf, 2007,6(5):609-621.
[4] Floyd JA, Galperin A, Ratner BD . Drug encapsulated polymeric microspheres for intracranial tumor therapy: A review of the literature[J]. Adv Drug Deliv Rev, 2015,91:23-37.
[5] 顼佳音, 杨洪军, 熊欣 , 等. 常见温度敏感型原位凝胶载体的研究进展[J]. 中国实验方剂学杂志, 2011,17(2):252-257.
[6] Elkharraz K, Faisant N, Guse C , et al. Paclitaxel-loaded micro-particles and implants for the treatment of brain cancer: Preparation and physicochemical characterization[J]. Int J Pharm, 2006,314(2):127-136.
[7] Dumortier G, Grossiord JL, Agnely F , et al. Areview of poloxamer 407 pharmaceutical and pharmacological characteristics[J]. Pharm Res, 2006,23(12):2709-2728.
[8] Shelke S, Shahi S, Jalalpure S , et al. Formulation and evaluation of thermoreversible mucoadhesive in situ gel for intranasal delivery of Naratriptan hydrochloride[J]. J Drug Deliv Sci Technol, 2015,29:238-244.
[9] Pluta J, Karolewicz B . In vitro studies of the properties of thermosensitive systems prepared on Pluronic F-127 as vehicles for me-thotrexate for delivery to solid tumours[J]. Polim Med, 2006,36(3):37-53.
[10] Feng L, Qi XR, Zhou XJ , et al. Pharmaceutical and immuno-logical evaluation of a single-dose hepatitis B vaccine using PLGA microspheres[J]. J Control Release, 2006,112(1):35-42.
[11] Shive MS, Anderson JM . Biodegradation and biocompatibility of PLA and PLGA microspheres[J]. Adv Drug Deliv Rev, 1997,28(1):5-24.
[12] 练有文, 王晖, 倪少凯 . BALB/c系裸小鼠脏器重量、脏器系数的测定[J]. 中国比较医学杂志, 2006,16(5):166-168.
[13] Zitzmann-Kolbe S, Strube A, Frisk AL , et al. 594 in vivo detection of mammary tumor and its lung metastases in the 4T1 metastasis mouse model by PET imaging using [F-18]-D-FMT (BAY 869596)[J]. EJC Suppl, 2010,8(7):186-187.
Outlines

/